All terms in EFO
| Label | Id | Description |
|---|---|---|
| binding site identification design | EFO_0004664 | |
| biomolecular annotation design | EFO_0004665 | |
| array specific design | EFO_0004668 | |
| methodological variation design | EFO_0004669 | |
| N-nervonoyl taurine measurement | EFO_0801190 | |
| NH4_C36:2 DAG_or_TAG_fragment measurement | EFO_0801198 | |
| NH4_C34:3 DAG_or_TAG_fragment measurement | EFO_0801197 | |
| NH4_C34:2 DAG_or_TAG_fragment measurement | EFO_0801196 | |
| Na_C34:2 DAG_or_TAG_fragment measurement | EFO_0801195 | |
| Na_C34:1 DAG_or_TAG_fragment measurement | EFO_0801194 | |
| N1-acetylspermidine measurement | EFO_0801193 | |
| N-palmitoyl taurine measurement | EFO_0801192 | |
| N-oleoyl taurine measurement | EFO_0801191 | |
| intraocular pressure measurement | EFO_0004695 | |
| sex hormone-binding globulin measurement | EFO_0004696 | |
| NH4_C36:3 DAG_or_TAG_fragment measurement | EFO_0801199 | |
| factor XI measurement | EFO_0004694 | |
| estradiol measurement | EFO_0004697 | |
| estrogen measurement | EFO_0011007 | |
| bone density conservation agent | CHEBI_50646 |